Tag: MCID
-
JAMA Touts Long COVID Exercise Trial with Clinically Insignificant Results; Most LC Exercise Trials Ignore PEM, Per Sick Times
In its current “Medical News in Brief” section, JAMA is touting and amplifying the questionable claims of a flawed trial to treat or prevent Long COVID published by one of the journals under its umbrella—JAMANetworkOpen. The JAMA headline: “Resistance Training Improves Long COVID Outcomes.” Technically, the headline is true. In the trial, participants who received…
-
Another Exercise Trial with Clinically Insignificant Findings
A recent study from JAMA Network Open, called “Resistance Exercise Therapy After COVID-19 Infection: A Randomized Clinical Trial,” demonstrates some of the flaws that so often mar papers in this field of research. The trial’s reported results do not warrant the optimistic conclusion that the intervention “may be a generalizable therapy for individuals with persisting…
-
Trudie Chalder Is Co-Author on Another Bad Exercise Paper
It is a truth universally acknowledged (or at least universally acknowledged by smart researchers), that if the list of authors on an article includes Trudie Chalder, King’s College London’s mathematically and factually challenged professor of cognitive behavior therapy, then the article in question should most assuredly be expected to be short on, or utterly devoid of, intelligence and logical reasoning.…
-
Did the IBS Trial Really Show that Web-Based CBT Offered Significant Clinical Effectiveness?
I wrote some posts last year about the ACTIB trial–a major study of telephone-delivered and web-delivered cognitive behavior therapy (TCBT and WCBT) for irritable bowel syndrome (IBS). Contrary to how the results have been framed by those with reputational and financial interests in promoting them, the study demonstrated that WCBT did not provide clinically significant…